Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

618 Articles

Paul Ausick | Aug 24, 2012 at 8:04 AM EDT

Alzheimer’s Drug Shows Some Success (LLY, PFE, ELN)

Drugmaker Eli Lilly & Co. (NYSE: LLY) announced this morning that the company’s solanezumab treatment for Alzheimer’s disease failed to…

Jon C. Ogg | Jul 30, 2012 at 8:41 AM EDT

Top Analyst Upgrades and Downgrades (NLY, CSH, CIEN, CRUS, DE, LLY, FSLR, JPM, HP, PETM, PSX, PHM, SNDK)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall St. research calls this Monday…

Paul Ausick | Jul 25, 2012 at 4:09 PM EDT

24/7 Wall St. Closing Bell — July 25, 2012: Markets Mixed on Spotty Earnings Reports

The three major US stock indexes opened mixed this morning with the Nasdaq Composite slightly negative on an unexpectedly weak…

Trey Thoelcke | Jul 25, 2012 at 8:11 AM EDT

Drug Giants Show Mixed Earnings (BMY, LLY)

Surging growth of its Cymbalta depression treatment helped Eli Lilly & Co. (NYSE: LLY) beat Wall St.’s earnings expectations. But…

Paul Ausick | Jul 24, 2012 at 4:05 PM EDT

24/7 Wall St. Closing Bell — July 24, 2012: Markets Fall on Weak Quarterly Results

The three major US stock indexes opened roughly flat this morning as Spanish 10-year bond yields rose to 7.5% and…

Paul Ausick | Jul 24, 2012 at 7:21 AM EDT

Pfizer’s Alzheimer’s Drug Fails Trial

A new treatment for Alzheimer’s disease from Pfizer Inc. (NYSE: PFE) and partner Elan Corp. plc (NYSE: ELN) has failed…

Paul Ausick | Jul 18, 2012 at 10:56 AM EDT

Top 10 U.S. Drugs for 2012 First Quarter

Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…

Paul Ausick | Jul 18, 2012 at 8:34 AM EDT

Abbott Labs Stung by Foreign Exchange Rate

Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…

Jon C. Ogg | Jul 3, 2012 at 7:35 AM EDT

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

GlobeImmune, Inc. is the latest biotech to file for an initial public offering. Financial terms were not disclosed but the…

Jon C. Ogg | Jun 30, 2012 at 9:45 AM EDT

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin…

Jon C. Ogg | May 18, 2012 at 7:47 AM EDT

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012…

Jon C. Ogg | May 10, 2012 at 12:02 PM EDT

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

It is now getting close to the middle of May, and that means one thing for biotech investors. The king…

Paul Ausick | Apr 23, 2012 at 7:59 AM EDT

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer.…

Jon C. Ogg | Mar 28, 2012 at 9:52 AM EDT

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

If there was a merger candidate which ever made sense in biotech and pharma it is Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN). …

Jon C. Ogg | Mar 23, 2012 at 8:49 AM EDT

Diabetes Drug Approved For Europe (AMLN, LLY)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) and Eli Lilly & Co. (NYSE: LLY) are in the news on the diabetes front. …

1 … 34 35 36 37 38 … 42

Eli Lilly : LLY

All Eli Lilly Articles

Alzheimer’s Drug Shows Some Success (LLY, PFE, ELN)

Top Analyst Upgrades and Downgrades (NLY, CSH, CIEN, CRUS, DE, LLY, FSLR, JPM, HP, PETM, PSX, PHM, SNDK)

24/7 Wall St. Closing Bell — July 25, 2012: Markets Mixed on Spotty Earnings Reports

Drug Giants Show Mixed Earnings (BMY, LLY)

24/7 Wall St. Closing Bell — July 24, 2012: Markets Fall on Weak Quarterly Results

Pfizer’s Alzheimer’s Drug Fails Trial

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

Diabetes Drug Approved For Europe (AMLN, LLY)

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Eli Lilly : LLY

All Eli Lilly Articles

Alzheimer’s Drug Shows Some Success (LLY, PFE, ELN)

Top Analyst Upgrades and Downgrades (NLY, CSH, CIEN, CRUS, DE, LLY, FSLR, JPM, HP, PETM, PSX, PHM, SNDK)

24/7 Wall St. Closing Bell — July 25, 2012: Markets Mixed on Spotty Earnings Reports

Drug Giants Show Mixed Earnings (BMY, LLY)

24/7 Wall St. Closing Bell — July 24, 2012: Markets Fall on Weak Quarterly Results

Pfizer’s Alzheimer’s Drug Fails Trial

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

Diabetes Drug Approved For Europe (AMLN, LLY)

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026